N. I. Klyushnikov
Research Subjects
N. I. Klyushnikov has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Elena Vladimirovna Gosteva
Voronezh State Medical Academy named after N.N. Burdenko, Russian Ministry of Health
4 shared publications - Lyudmila V. Vasilieva
N. N. Burdenko Voronezh State Medical University
3 shared publications - Ol'Ga A. Osipova
Belgorod State National Research University
3 shared publications - Svetlana G. Gorelik
Belgorod National Research University
3 shared publications - Yuri A. Lykov
Belgorod National Research University
3 shared publications - Andrey Nikolaevich Ilnitski
Autonomous non-profit Organization Research Medical Center “Gerontology
2 shared publications
Latest Publications
- 20 October 2025
- Published by Autonomous non-profit organization-Society of Specialists in the Field Innovative Medical Technology in Russian Journal of Geriatric Medicine
- No. 3
Rehabilitation of patients with sarcopenic obesity within the framework of the Active Longevity project
BACKGROUND. The Russian government has set itself an ambitious goal – to significantly increase both the duration and quality of life of citizens, paying special attention to the older generation. The promotion and comprehensive support of active longevity is becoming a key area of government policy. The essence of this strategy is to maximize the involvement of older people in work and social life, which, in turn, has a positive effect on their physical and psychological condition. Voronezhstat data for 2024 indicate that pensioners make up an impressive 42 % of the population of the Voronezh Region. This figure clearly demonstrates the scale of the task facing the regional authorities to ensure a decent life and social adaptation of the older generation.OBJECTIVE. To determine the effectiveness of a recovery program for 65-year-old women with sarcopenic obesity.MATERIALS AND METHODS. The study involved 60 people selected according to certain criteria. The studied patients were classified according to the presence or absence of sarcopenic obesity. To analyze the effectiveness of rehabilitation intervention, two groups were formed: experimental and control. For 6 months, the participants of the experimental group, in addition to traditional treatment, underwent a rehabilitation program developed at the N. N. Burdenko State Medical University. The program included physical exercises, dosed according to the condition and functional capabilities of the patients, as well as a high-protein diet (1.0 g/kg/day). The Sports Complex (SC) of the N. N. Burdenko VSMU, as part of the program for the rehabilitation of the elderly, offers a course of 10 thematic classes organized in a scientifically based manner for this category of patients. Classes lasting 60 minutes are held 2 times a week for 6 months in a certain sequence. On the first day, a group is formed and an introductory lecture is held. Participants are explained the principles of the program, rules of conduct, individual wishes are taken into account. A medical examination is conducted by a doctor to identify health problems. The day ends with an introductory complex of therapeutic gymnastics and an introduction to the psychologist. The second session starts with therapeutic gymnastics and continues in the phytobar with a discussion of physiological changes in old age with basic recommendations. The third day includes therapeutic gymnastics in the gym and a talk on the prevention of aging of the musculoskeletal system, as well as an introductory chiropractic procedure. The fourth day includes a session in the swimming pool and discussion of the basics of proper nutrition and modern diets, principles of healthy lifestyle. The fifth session - discussion of techniques and performance of breathing exercises and inhalations. The sixth day - exercise machines, discussion about skin care and anti-cellulite massage, doctor's examination. The seventh session - dosed walking and a talk about its role in longevity. Eighth session - Nordic walking and a talk about its principles, pros and cons, a session with a psychologist. The program is completed by a walk in nature (ninth day) and a relaxation complex of therapeutic gymnastics (tenth day).RESULTS. In the experimental group of patients suffering from sarcopenic obesity, statistically significant changes in anthropometry and quality of life were found after the rehabilitation course. There was a significant decrease in weight (from 90.1 kg to 84.2 kg; p < 0.001) and body mass index (BMI) (from 32.8 kg/m2 to 30.9 kg/m2; p < 0.001). At the same time, after rehabilitation measures, there was a noticeable increase in absolute (from 14.8 kg to 16.2 kg; p < 0.001) and relative (from 16% to 22%; p < 0.001) muscle mass, as well as the MMI/BMI ratio (from 0.459 to 0.583; p < 0.001). The assessment of quality of life revealed a significant decrease in the overall score, which indicates an improvement in various aspects of life in these patients. Statistically significant changes in anthropometric indicators and quality of life assessment were also recorded in patients of the experimental group without sarcopenic obesity. There was a marked decrease in body weight (from 80.0 kg to 74.9 kg; p = 0.001) and BMI (from 28.2 kg/m2 to 25.3 kg/m2; p < 0.001 CONCLUSION. Regular physical activity, especially of an aerobic nature, stimulates the mechanisms of muscle tissue repair. In addition to building muscle mass, they have a positive effect on the functioning of the heart and blood vessels of the brain, which is especially important for overweight people.
- 20 October 2025
- Published by Autonomous non-profit organization-Society of Specialists in the Field Innovative Medical Technology in Russian Journal of Geriatric Medicine
- No. 3
Rehabilitation of patients with sarcopenic obesity within the framework of the Active Longevity project
BACKGROUND. The Russian government has set itself an ambitious goal – to significantly increase both the duration and quality of life of citizens, paying special attention to the older generation. The promotion and comprehensive support of active longevity is becoming a key area of government policy. The essence of this strategy is to maximize the involvement of older people in work and social life, which, in turn, has a positive effect on their physical and psychological condition. Voronezhstat data for 2024 indicate that pensioners make up an impressive 42 % of the population of the Voronezh Region. This figure clearly demonstrates the scale of the task facing the regional authorities to ensure a decent life and social adaptation of the older generation.OBJECTIVE. To determine the effectiveness of a recovery program for 65-year-old women with sarcopenic obesity.MATERIALS AND METHODS. The study involved 60 people selected according to certain criteria. The studied patients were classified according to the presence or absence of sarcopenic obesity. To analyze the effectiveness of rehabilitation intervention, two groups were formed: experimental and control. For 6 months, the participants of the experimental group, in addition to traditional treatment, underwent a rehabilitation program developed at the N. N. Burdenko State Medical University. The program included physical exercises, dosed according to the condition and functional capabilities of the patients, as well as a high-protein diet (1.0 g/kg/day). The Sports Complex (SC) of the N. N. Burdenko VSMU, as part of the program for the rehabilitation of the elderly, offers a course of 10 thematic classes organized in a scientifically based manner for this category of patients. Classes lasting 60 minutes are held 2 times a week for 6 months in a certain sequence. On the first day, a group is formed and an introductory lecture is held. Participants are explained the principles of the program, rules of conduct, individual wishes are taken into account. A medical examination is conducted by a doctor to identify health problems. The day ends with an introductory complex of therapeutic gymnastics and an introduction to the psychologist. The second session starts with therapeutic gymnastics and continues in the phytobar with a discussion of physiological changes in old age with basic recommendations. The third day includes therapeutic gymnastics in the gym and a talk on the prevention of aging of the musculoskeletal system, as well as an introductory chiropractic procedure. The fourth day includes a session in the swimming pool and discussion of the basics of proper nutrition and modern diets, principles of healthy lifestyle. The fifth session - discussion of techniques and performance of breathing exercises and inhalations. The sixth day - exercise machines, discussion about skin care and anti-cellulite massage, doctor's examination. The seventh session - dosed walking and a talk about its role in longevity. Eighth session - Nordic walking and a talk about its principles, pros and cons, a session with a psychologist. The program is completed by a walk in nature (ninth day) and a relaxation complex of therapeutic gymnastics (tenth day).RESULTS. In the experimental group of patients suffering from sarcopenic obesity, statistically significant changes in anthropometry and quality of life were found after the rehabilitation course. There was a significant decrease in weight (from 90.1 kg to 84.2 kg; p < 0.001) and body mass index (BMI) (from 32.8 kg/m2 to 30.9 kg/m2; p < 0.001). At the same time, after rehabilitation measures, there was a noticeable increase in absolute (from 14.8 kg to 16.2 kg; p < 0.001) and relative (from 16% to 22%; p < 0.001) muscle mass, as well as the MMI/BMI ratio (from 0.459 to 0.583; p < 0.001). The assessment of quality of life revealed a significant decrease in the overall score, which indicates an improvement in various aspects of life in these patients. Statistically significant changes in anthropometric indicators and quality of life assessment were also recorded in patients of the experimental group without sarcopenic obesity. There was a marked decrease in body weight (from 80.0 kg to 74.9 kg; p = 0.001) and BMI (from 28.2 kg/m2 to 25.3 kg/m2; p < 0.001 CONCLUSION. Regular physical activity, especially of an aerobic nature, stimulates the mechanisms of muscle tissue repair. In addition to building muscle mass, they have a positive effect on the functioning of the heart and blood vessels of the brain, which is especially important for overweight people.
- Open Access
- 20 October 2025
- Published by Autonomous non-profit organization-Society of Specialists in the Field Innovative Medical Technology in Russian Journal of Geriatric Medicine
- No. 3,p. 431-433
Association of sarcopenia with systemic immune inflammatory index in elderly patients
The relationship between the immune inflammatory index (SII) and sarcopenia in older patients, specifically in terms of muscle mass and relative strength, was assessed. The SII has shown promising predictive ability and high efficacy in identifying decreased muscle function among older individuals.BACKGROUND. In elderly people, sarcopenia can lead to a decrease in functional activity and the ability to perform self-care activities, as well as an increased risk of falling. A general blood test is a common laboratory test that can be used to measure various components that can act as markers for inflammation. The SII index, which is calculated by multiplying the number of platelets by neutrophils and dividing by lymphocytes, is more accurate than C-reactive protein in predicting coronary heart disease. It can also effectively predict the development and progression of heart failure. However, the relationship between sarcopenia and the SII index has not yet been fully investigated.THE OBJECTIVE OF THE STUDY ― to investigate the relationship between the inflammatory index SII (platelet-neutrophil ratio/lymphocyte count) and muscle mass and strength.MATERIALS AND METHODS. The study included 65 elderly men with an average age of 70.4 ± 3.2 year. Sarcopenia was diagnosed using the EWGSOP criteria. The participants were divided into two groups: group 1 included 32 men with sarcopenia, and group 2 included 33 men without sarcopenia. The inclusion criteria were: the age of the patients was 60–74 years, and all stages of the study had been completed.Muscle mass index (MMI) was determined by dividing muscle mass by body mass index (BMI). For men, an MMI below 0.789 was considered low. Grip strength was measured by squeezing a dynamometer in each hand 3 times for 5 seconds, and the average value was taken. The elbow was positioned at a right angle to the body. Relative Strength Index (RSI) was calculated by dividing dominant arm muscle strength by BMI.Statistical analysis was performed using ROC analysis to evaluate MMI in predicting low muscle mass and strength risk. Spearman's correlation analysis was used to assess the relationship between SII, MMI, and muscle strength.RESULTS. Patients with sarcopenia had a significantly higher BMI (p < 0.001, mean (32.03 ± 6.28) kg/m²) compared to those without sarcopenia (mean (25.98 ± 5.03) kg/m²). They also had lower BMI (mean 0.68 ± 0.09 vs 0.87 ± 0.06) and BMI (1.12 ± 0.17 vs 1.52 ± 0.23). An increase in BMI was associated with a decrease in RSI.Patients without sarcopenia had lower platelet and lymphocyte counts. The SII value was significantly higher in patients with sarcopenia (548.36 ± 232.63) compared to those without (414.42 ± 205.25, pCONCLUSION. The SII index has demonstrated reliable predictive ability and high efficiency in detecting decreased muscle function in elderly patients.
- 20 October 2025
- Published by Autonomous non-profit organization-Society of Specialists in the Field Innovative Medical Technology in Russian Journal of Geriatric Medicine
- No. 3,p. 431-433
Open AccessAssociation of sarcopenia with systemic immune inflammatory index in elderly patients
The relationship between the immune inflammatory index (SII) and sarcopenia in older patients, specifically in terms of muscle mass and relative strength, was assessed. The SII has shown promising predictive ability and high efficacy in identifying decreased muscle function among older individuals.BACKGROUND. In elderly people, sarcopenia can lead to a decrease in functional activity and the ability to perform self-care activities, as well as an increased risk of falling. A general blood test is a common laboratory test that can be used to measure various components that can act as markers for inflammation. The SII index, which is calculated by multiplying the number of platelets by neutrophils and dividing by lymphocytes, is more accurate than C-reactive protein in predicting coronary heart disease. It can also effectively predict the development and progression of heart failure. However, the relationship between sarcopenia and the SII index has not yet been fully investigated.THE OBJECTIVE OF THE STUDY ― to investigate the relationship between the inflammatory index SII (platelet-neutrophil ratio/lymphocyte count) and muscle mass and strength.MATERIALS AND METHODS. The study included 65 elderly men with an average age of 70.4 ± 3.2 year. Sarcopenia was diagnosed using the EWGSOP criteria. The participants were divided into two groups: group 1 included 32 men with sarcopenia, and group 2 included 33 men without sarcopenia. The inclusion criteria were: the age of the patients was 60–74 years, and all stages of the study had been completed.Muscle mass index (MMI) was determined by dividing muscle mass by body mass index (BMI). For men, an MMI below 0.789 was considered low. Grip strength was measured by squeezing a dynamometer in each hand 3 times for 5 seconds, and the average value was taken. The elbow was positioned at a right angle to the body. Relative Strength Index (RSI) was calculated by dividing dominant arm muscle strength by BMI.Statistical analysis was performed using ROC analysis to evaluate MMI in predicting low muscle mass and strength risk. Spearman's correlation analysis was used to assess the relationship between SII, MMI, and muscle strength.RESULTS. Patients with sarcopenia had a significantly higher BMI (p < 0.001, mean (32.03 ± 6.28) kg/m²) compared to those without sarcopenia (mean (25.98 ± 5.03) kg/m²). They also had lower BMI (mean 0.68 ± 0.09 vs 0.87 ± 0.06) and BMI (1.12 ± 0.17 vs 1.52 ± 0.23). An increase in BMI was associated with a decrease in RSI.Patients without sarcopenia had lower platelet and lymphocyte counts. The SII value was significantly higher in patients with sarcopenia (548.36 ± 232.63) compared to those without (414.42 ± 205.25, pCONCLUSION. The SII index has demonstrated reliable predictive ability and high efficiency in detecting decreased muscle function in elderly patients.
- 3 October 2022
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 21 (9)
Advantages of telmisartan pharmacotherapy in elderly patients with arterial hypertension and metabolic syndrome who have suffered an ischemic stroke
Aim . To compare the effectiveness of telmisartan and perindopril in the treatment of elderly patients with arterial hypertension (AH) and metabolic syndrome (MS) who have suffered ischemic stroke (IS). Material and methods . 92 elderly patients with AH and MS who underwent IS (mean 68±4 years) were examined. Patients were randomly divided into pharmacotherapy groups: 47 patients took telmisartan (80 mg/day) and 45 — perindopril (10 mg/day). Fasting plasma glucose levels, insulin, leptin, total cholesterol, triglycerides, highand lowdensity lipoprotein cholesterol were determined, the HOMA-IR index was calculated, and daily monitoring was performed. Statistical processing was carried out using STATISTICA 10,0. The indicators are presented in the form of the median, interquartile ranges of Me (Q25%; Q75%), and mean ±SD. The comparison was carried out using the Wilcoxon rank criterion. The differences are significant at pResults . After 12 months of observation in the telmisartan group, there was a significant decrease in the average daily systolic blood pressure (ВРs) from 152 (146; 156) to 129 (125; 134) mm Hg (pConclusion . Elderly patients with hypertension on the background of MS and a history of IS had significantly decreased ВРs and ВРd (according to the results of daily monitoring) after 12 months of telmisartan pharmacotherapy, decreased insulin resistance and the level of leptin and triglycerides in the blood serum.
- 3 October 2022
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 21 (9)
Advantages of telmisartan pharmacotherapy in elderly patients with arterial hypertension and metabolic syndrome who have suffered an ischemic stroke
Aim . To compare the effectiveness of telmisartan and perindopril in the treatment of elderly patients with arterial hypertension (AH) and metabolic syndrome (MS) who have suffered ischemic stroke (IS). Material and methods . 92 elderly patients with AH and MS who underwent IS (mean 68±4 years) were examined. Patients were randomly divided into pharmacotherapy groups: 47 patients took telmisartan (80 mg/day) and 45 — perindopril (10 mg/day). Fasting plasma glucose levels, insulin, leptin, total cholesterol, triglycerides, highand lowdensity lipoprotein cholesterol were determined, the HOMA-IR index was calculated, and daily monitoring was performed. Statistical processing was carried out using STATISTICA 10,0. The indicators are presented in the form of the median, interquartile ranges of Me (Q25%; Q75%), and mean ±SD. The comparison was carried out using the Wilcoxon rank criterion. The differences are significant at pResults . After 12 months of observation in the telmisartan group, there was a significant decrease in the average daily systolic blood pressure (ВРs) from 152 (146; 156) to 129 (125; 134) mm Hg (pConclusion . Elderly patients with hypertension on the background of MS and a history of IS had significantly decreased ВРs and ВРd (according to the results of daily monitoring) after 12 months of telmisartan pharmacotherapy, decreased insulin resistance and the level of leptin and triglycerides in the blood serum.
- Open Access
- 3 October 2022
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 21 (9) , 3390
Advantages of telmisartan pharmacotherapy in elderly patients with arterial hypertension and metabolic syndrome who have suffered an ischemic stroke
Aim. To compare the effectiveness of telmisartan and perindopril in the treatment of elderly patients with arterial hypertension (AH) and metabolic syndrome (MS) who have suffered ischemic stroke (IS).Material and methods. 92 elderly patients with AH and MS who underwent IS (mean 68±4 years) were examined. Patients were randomly divided into pharmacotherapy groups: 47 patients took telmisartan (80 mg/day) and 45 — perindopril (10 mg/day). Fasting plasma glucose levels, insulin, leptin, total cholesterol, triglycerides, highand lowdensity lipoprotein cholesterol were determined, the HOMA-IR index was calculated, and daily monitoring was performed. Statistical processing was carried out using STATISTICA 10,0. The indicators are presented in the form of the median, interquartile ranges of Me (Q25%; Q75%), and mean ±SD. The comparison was carried out using the Wilcoxon rank criterion. The differences are significant at pResults. After 12 months of observation in the telmisartan group, there was a significant decrease in the average daily systolic blood pressure (ВРs) from 152 (146; 156) to 129 (125; 134) mm Hg (pConclusion. Elderly patients with hypertension on the background of MS and a history of IS had significantly decreased ВРs and ВРd (according to the results of daily monitoring) after 12 months of telmisartan pharmacotherapy, decreased insulin resistance and the level of leptin and triglycerides in the blood serum.
- 3 October 2022
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 21 (9) , 3390
Open AccessAdvantages of telmisartan pharmacotherapy in elderly patients with arterial hypertension and metabolic syndrome who have suffered an ischemic stroke
Aim. To compare the effectiveness of telmisartan and perindopril in the treatment of elderly patients with arterial hypertension (AH) and metabolic syndrome (MS) who have suffered ischemic stroke (IS).Material and methods. 92 elderly patients with AH and MS who underwent IS (mean 68±4 years) were examined. Patients were randomly divided into pharmacotherapy groups: 47 patients took telmisartan (80 mg/day) and 45 — perindopril (10 mg/day). Fasting plasma glucose levels, insulin, leptin, total cholesterol, triglycerides, highand lowdensity lipoprotein cholesterol were determined, the HOMA-IR index was calculated, and daily monitoring was performed. Statistical processing was carried out using STATISTICA 10,0. The indicators are presented in the form of the median, interquartile ranges of Me (Q25%; Q75%), and mean ±SD. The comparison was carried out using the Wilcoxon rank criterion. The differences are significant at pResults. After 12 months of observation in the telmisartan group, there was a significant decrease in the average daily systolic blood pressure (ВРs) from 152 (146; 156) to 129 (125; 134) mm Hg (pConclusion. Elderly patients with hypertension on the background of MS and a history of IS had significantly decreased ВРs and ВРd (according to the results of daily monitoring) after 12 months of telmisartan pharmacotherapy, decreased insulin resistance and the level of leptin and triglycerides in the blood serum.
- Open Access
- 8 January 2022
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 20 (8) , 3087
Dynamics of fibrotic and vascular endothelial dysfunction markers in elderly hypertensive patients after ischemic stroke receiving beta-blockers
Aim. To compare the effect of beta-blocker therapy (bisoprolol and nebivolol) on the dynamics of fibrotic and vascular endothelial dysfunction markers in elderly hypertensive patients after ischemic stroke (IS).Material and methods. This prospective cohort study included 75 hypertensive patients who were admitted to the hospital due to IS. The mean age of patients was 67±6 years. The average National Institutes of Health Stroke Scale (NIHSS) score was 7±3. The followup period was 6 months. The control group consisted of 20 elderly people with hypertension without prior myocardial infarction. The patients were divided into groups based on received therapy: group 1 (n=38) — bisoprolol; group 2 (n=37) — nebivolol. The level of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) was determined by enzyme-linked immunosorbent assay (ELISAKit, USA). Vascular ultrasound was carried out using a LOGIQP9 (GE) system according to the Celermajer method.Results. After 6-month nebivolol, we revealed a decrease in the level of MMP-9 by 30,2% (pConclusion. The results obtained indicate that the beta-blocker nebivolol at an average dose of 8,55+1,75 mg/day significantly reduces the vascular fibrosis, normalizes the ratio of collagen synthesis and degradation markers, improves the vasodilation brachial artery properties in comparison with bisoprolol in elderly hypertensive patients after IS.
- 8 January 2022
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 20 (8) , 3087
Open AccessDynamics of fibrotic and vascular endothelial dysfunction markers in elderly hypertensive patients after ischemic stroke receiving beta-blockers
Aim. To compare the effect of beta-blocker therapy (bisoprolol and nebivolol) on the dynamics of fibrotic and vascular endothelial dysfunction markers in elderly hypertensive patients after ischemic stroke (IS).Material and methods. This prospective cohort study included 75 hypertensive patients who were admitted to the hospital due to IS. The mean age of patients was 67±6 years. The average National Institutes of Health Stroke Scale (NIHSS) score was 7±3. The followup period was 6 months. The control group consisted of 20 elderly people with hypertension without prior myocardial infarction. The patients were divided into groups based on received therapy: group 1 (n=38) — bisoprolol; group 2 (n=37) — nebivolol. The level of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) was determined by enzyme-linked immunosorbent assay (ELISAKit, USA). Vascular ultrasound was carried out using a LOGIQP9 (GE) system according to the Celermajer method.Results. After 6-month nebivolol, we revealed a decrease in the level of MMP-9 by 30,2% (pConclusion. The results obtained indicate that the beta-blocker nebivolol at an average dose of 8,55+1,75 mg/day significantly reduces the vascular fibrosis, normalizes the ratio of collagen synthesis and degradation markers, improves the vasodilation brachial artery properties in comparison with bisoprolol in elderly hypertensive patients after IS.